adalimumab vs aspirin

According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.

Side-by-side comparison of adalimumab and aspirin. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
adalimumab TNF-Alpha Inhibitor (Biologic)
aspirin Antiplatelet / NSAID
Type
adalimumab Prescription
aspirin Over-the-Counter
Summary
adalimumab

Idacio is a medicine that blocks a protein called TNF. It is used to treat several diseases, including arthritis and Crohn's disease.

aspirin

Aspirin is a common medicine used to relieve minor pain. It can also be prescribed by your doctor for other uses.

What It Treats
adalimumab

Idacio can help adults with rheumatoid arthritis by reducing joint pain and damage. It can also help children (2 years and older) with juvenile idiopathic arthritis. Idacio treats psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and uveitis.

aspirin

Aspirin is used to temporarily relieve minor aches and pains. However, it works slowly. It will not quickly relieve headaches or other symptoms that need immediate relief. Ask your doctor about other uses for this medicine.

How It Works
adalimumab

Idacio works by blocking a protein in your body called tumor necrosis factor (TNF). TNF can cause inflammation and damage in certain diseases. By blocking TNF, Idacio can reduce these symptoms.

aspirin

Aspirin belongs to a class of drugs called NSAIDs and antiplatelets. It works by reducing substances in the body that cause pain and inflammation. It also helps to prevent blood clots.

Common Side Effects
adalimumab
  • Infections (like colds or sinus infections)
  • Injection site reactions (redness, itching, pain, or swelling)
  • Headache
  • Rash
aspirin
  • Upset stomach
  • Heartburn
FAERS Reports
adalimumab
  • Pain 49,062
  • Arthralgia 48,039
  • Injection Site Pain 47,251
  • Fatigue 39,111
  • Rheumatoid Arthritis 35,573
aspirin
  • Fatigue 31,963
  • Dyspnoea 27,179
  • Nausea 26,579
  • Diarrhoea 26,452
  • Dizziness 22,390
Serious Warnings
adalimumab

Idacio can increase your risk of serious infections that could lead to hospitalization or death. Tell your doctor if you have any infections before starting Idacio. Idacio may also increase your risk of certain cancers, including lymphoma. Children and teens taking TNF blockers like Idacio have developed rare, aggressive cancers.

aspirin

No specific warnings noted.

Pregnancy
adalimumab

Tell your doctor if you are pregnant or plan to become pregnant. Idacio can cross the placenta and may affect your baby's immune system. Talk to your doctor about vaccines for your baby if you took Idacio during pregnancy.

aspirin

Ask your doctor for advice if you are pregnant or breastfeeding.

Also Compare, Nearby Drugs

How to Read This adalimumab vs aspirin Comparison

adalimumab is classified in the TNF-Alpha Inhibitor (Biologic) drug class, while aspirin sits within the Antiplatelet / NSAID class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adalimumab has 219,036 submissions while aspirin has 134,563. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for adalimumab or aspirin.

Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.